Imax (IMAX) Stock Price Target 2026

The average analyst price target for Imax is $53.67, 9.9% above the current price. Of 13 analysts, 12 rate it Buy and 1 Hold. Targets range from $28 to $65. The latest change came on Nov 6, 2026, when Wedbush raised its price target on Imax from $60 to $62 and kept an Outperform rating.

The Average Analyst Price Target for Imax is $53.67.

Price Target Range — 10 Quarters

Analyst Consensus — 13 Analysts

12Buy

1Hold

Consensus RatingBuy# Analysts13Avg. Consensus PT$53.67Upside to Avg. PT+9.9%

Rating Trend — Last 9 Months

Latest Upgrades and Downgrades for Imax Stock

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
Nov 6, 2026	Wedbush	Alicia Reese	PT Raise	Outperform	$60→$62
Nov 6, 2026	Wells Fargo	Omar Mejias	PT Cut	Equal-Weight	$55→$52
Oct 23, 2026	JP Morgan	David Karnovsky	PT Raise	Overweight	$50→$58
Oct 15, 2026	Wells Fargo	Omar Mejias	PT Raise	Equal-Weight	$45→$55
Oct 14, 2026	Wedbush	Alicia Reese	PT Raise	Outperform	$54→$60
Oct 14, 2026	Rosenblatt	Steve Frankel	Maintained	Buy	$65
Oct 8, 2026	B. Riley Securities	Drew Crum	PT Raise	Buy	$61→$64
Oct 7, 2026	StoneX	Mike Hickey	PT Raise	Buy	$60→$65
Sep 24, 2026	Morgan Stanley	Daniel Duran	Initiate	Overweight	$63
Sep 9, 2026	Rosenblatt	Steve Frankel	PT Raise	Buy	$60→$65
Sep 4, 2026	Goldman Sachs	Mike Burton	PT Raise	Neutral	$42→$50
Sep 3, 2026	Roth Capital	Eric Handler	PT Raise	Buy	$50→$60
Sep 2, 2026	Macquarie	Chad Beynon	PT Raise	Outperform	$50→$55
Aug 24, 2026	B. Riley Securities	Drew Crum	PT Raise	Buy	$52→$61
Aug 19, 2026	Rosenblatt	Steve Frankel	Maintained	Buy	$60
Aug 10, 2026	Rosenblatt	Steve Frankel	PT Raise	Buy	$50→$60
Jul 24, 2026	Barrington Research	Patrick Sholl	PT Raise	Outperform	$46→$50
Jul 24, 2026	JP Morgan	David Karnovsky	PT Raise	Overweight	$47→$50
Jul 24, 2026	Roth Capital	Eric Handler	PT Raise	Buy	$48→$50
Jul 24, 2026	B. Riley Securities	Drew Crum	PT Raise	Buy	$48→$52